# KAI Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kai-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: South San Francisco, US
- Total disclosed funding: $63M
- Latest round: Series B (May 1, 2006)
- Investors on record: 8

## About

Founded in 2002 and based in California, US, KAI Pharmaceuticals Inc. is a biopharmaceutical company that develops and manufactures therapeutics for chronic ailments of the kidneys, heart, and bones.

## Funding rounds

- Series B, May 1, 2006, $35M — Delphi Ventures, Intersouth Partners, InterWest Partners, Aberdare Ventures, Skyline Ventures, Patricia Industries, TWP Private Wealth Management, Lumira Ventures
- Series A, Oct 26, 2004, $11M — Delphi Ventures, Intersouth Partners, InterWest Partners, Skyline Ventures, TWP Private Wealth Management, Lumira Ventures
- Series A, Dec 4, 2003, $17M — Delphi Ventures, Intersouth Partners, InterWest Partners, Skyline Ventures

## Investors

- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series A, Series B
- Intersouth Partners (https://capitalatlas.ai/funds/intersouth-partners) — Series A, Series B
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series A, Series B
- Skyline Ventures (https://capitalatlas.ai/funds/skyline-ventures) — Series A, Series B
- TWP Private Wealth Management (https://capitalatlas.ai/funds/twp-private-wealth-management) — Series A, Series B
- Lumira Ventures (https://capitalatlas.ai/funds/lumira-ventures) — Series A, Series B
- Aberdare Ventures (https://capitalatlas.ai/funds/aberdare-ventures) — Series B
- Patricia Industries (https://capitalatlas.ai/funds/patricia-industries) — Series B